Peter Anderson, MD
Otolaryngology · West Jordan, UTNPI 1043444516
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $2,723 of the $3,740 with a category attached, or 72.8%. Intersect ENT, Inc. accounts for 68.3% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2019 at $2,533 and has fallen 91.5% since, to $216 in 2025.
Across 35 payments — averaging $106.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intersect ENT, Inc.$3K
- Stryker$931
- Optinose US, Inc.$67
- Regeneron Healthcare Solutions, Inc.$52
- AbbVie$35
- Cochlear Americas$23
- plus $78 from 5 others
What the payments were for
- Consulting fees$1003%
- Travel & lodging$2,72373%
- Food & beverage$91725%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intersect ENT, Inc. | 11 | $2,555 |
| Stryker | 10 | $931 |
| Optinose US, Inc. | 4 | $67 |
| Regeneron Healthcare Solutions, Inc. | 2 | $52 |
| AbbVie | 2 | $35 |
| Cochlear Americas | 1 | $23 |
| GSK | 1 | $18 |
| Aerin Medical Inc. | 1 | $18 |
| Pfizer | 1 | $15 |
| Boston Scientific | 1 | $15 |
| Medtronic | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROPEL$2,441
- SINUVA$2,341
- SCOPIS ENT$701
How this compares
$3,740 in reported general payments places this provider in the 75th percentile of 104 otolaryngology providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 46 | $1,334 |
| Fluticasone Propionate | 35 | $711 |
| Montelukast Sodium | 36 | $334 |
| Omeprazole | 25 | $266 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 18 | $213 |
| Amitriptyline Hcl | 21 | $194 |
| Mupirocin | 21 | $165 |
| Methylprednisolone | 17 | $141 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 16 | $56 |
| Levothyroxine Sodium | 12 | $35 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in West Jordan
- John BitnerLayton$177K
- Steven MillerSalt Lake City$32K
- Michael WilsonSalt Lake City$16K
- Kevin WilsonDraper$13K
- Jerry SonkensSlc$12K
- Matthew DahlSalt Lake City$12K
- Seth RiddleProvo$10K
- Heidi HerasAmerican Fork$9K
- Douglas AndersonOgden$9K
- Scott ShipleyProvo$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.